These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 16138320)
1. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET. Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L Synapse; 2005 Dec; 58(3):173-83. PubMed ID: 16138320 [TBL] [Abstract][Full Text] [Related]
2. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain. Lundberg J; Odano I; Olsson H; Halldin C; Farde L J Nucl Med; 2005 Sep; 46(9):1505-15. PubMed ID: 16157534 [TBL] [Abstract][Full Text] [Related]
3. A radiometabolite study of the serotonin transporter PET radioligand [(11)C]MADAM. Gourand F; Emond P; Bergström JP; Takano A; Gulyás B; Guilloteau D; Barré L; Halldin C Nucl Med Biol; 2014 Jul; 41(6):501-6. PubMed ID: 24857865 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography. Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664 [TBL] [Abstract][Full Text] [Related]
5. Validation of two fluoro-analogues of N,N-dimethyl-2-(2'-amino-4'-hydroxymethyl-phenylthio)benzylamine as serotonin transporter imaging agents using microPET. Jarkas N; Voll RJ; Williams L; Goodman MM Nucl Med Biol; 2010 Jul; 37(5):593-603. PubMed ID: 20610164 [TBL] [Abstract][Full Text] [Related]
6. [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. Halldin C; Erixon-Lindroth N; Pauli S; Chou YH; Okubo Y; Karlsson P; Lundkvist C; Olsson H; Guilloteau D; Emond P; Farde L Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1220-30. PubMed ID: 12811422 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity. Chalon S; Tarkiainen J; Garreau L; Hall H; Emond P; Vercouillie J; Farde L; Dasse P; Varnas K; Besnard JC; Halldin C; Guilloteau D J Pharmacol Exp Ther; 2003 Jan; 304(1):81-7. PubMed ID: 12490578 [TBL] [Abstract][Full Text] [Related]
8. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. Halldin C; Foged C; Chou YH; Karlsson P; Swahn CG; Sandell J; Sedvall G; Farde L J Nucl Med; 1998 Dec; 39(12):2061-8. PubMed ID: 9867142 [TBL] [Abstract][Full Text] [Related]
9. Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study. Lundberg J; Halldin C; Farde L Synapse; 2006 Sep; 60(3):256-63. PubMed ID: 16752362 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands. Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744 [TBL] [Abstract][Full Text] [Related]
11. Carbon-11 HOMADAM: a novel PET radiotracer for imaging serotonin transporters. Jarkas N; Votaw JR; Voll RJ; Williams L; Camp VM; Owens MJ; Purselle DC; Bremner JD; Kilts CD; Nemeroff CB; Goodman MM Nucl Med Biol; 2005 Apr; 32(3):211-24. PubMed ID: 15820756 [TBL] [Abstract][Full Text] [Related]
12. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics. Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain. Bergström KA; Halldin C; Hall H; Lundkvist C; Ginovart N; Swahn CG; Farde L Eur J Nucl Med; 1997 Jun; 24(6):596-601. PubMed ID: 9169564 [TBL] [Abstract][Full Text] [Related]
14. Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats. Lundquist P; Roman M; Syvänen S; Hartvig P; Blomquist G; Hammarlund-Udenaes M; Långström B Synapse; 2007 Jun; 61(6):440-9. PubMed ID: 17372973 [TBL] [Abstract][Full Text] [Related]
15. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems. Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138 [TBL] [Abstract][Full Text] [Related]
16. Temperament, character and serotonin activity in the human brain: a positron emission tomography study based on a general population cohort. Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Cloninger CR; Raitakari O; Hietala J; Keltikangas-Järvinen L Psychol Med; 2013 Apr; 43(4):881-94. PubMed ID: 22850434 [TBL] [Abstract][Full Text] [Related]
17. Characterization of FlipIDAM as a SERT-selective SPECT imaging agent. Lemoine L; Lieberman BP; Ploessl K; Zheng P; Kung HF Nucl Med Biol; 2013 Oct; 40(7):879-86. PubMed ID: 23856117 [TBL] [Abstract][Full Text] [Related]
18. A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain. Lundberg J; Borg J; Halldin C; Farde L Psychopharmacology (Berl); 2007 Dec; 195(3):425-33. PubMed ID: 17874074 [TBL] [Abstract][Full Text] [Related]
19. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo. Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162 [TBL] [Abstract][Full Text] [Related]